Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease Bárbara Rita Cardoso,1 Cristiane Cominetti,2 Silvia Maria Franciscato Cozzolino11Faculty of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, Brazil; 2Faculty of Nutrition, Federal University of Goiás, Goiás, BrazilAbstract: Alzheimer’s disease (AD) is the most common form of dementia, and it generally affects the elderly. It has been suggested that diet is an intensively modifiable lifestyle factor that might reduce the risk of AD. Because epidemiological studies generally report the potential neuronal protective effects of various micronutrients, the aim of this study was to perform a literature review on the major nutrients that are related to AD, including selenium, vitamins C and E, transition metals, vitamin D, B-complex vitamins, and omega-3 fatty acids.Keywords: Alzheimer’s disease, nutritional deficiencies, diet, oxidative stress, lipid, vitamins
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 1×
“age, gender, apolipoprotein E (ApoE) genotype and serum folate, vitamin B6, and vitamin B12 concentrations.(98)”
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522
Selenium in human health and disease
Fairweather-Tait, S. J., Bao, Y., Broadley, M. R., Collings, R., Ford, D., Hesketh, J. E., & Hurst, R. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3275 · Cited by 1,330
Counting the Zinc-Proteins Encoded in the Human Genome
Andreini, C., Banci, L., Bertini, I., & Rosato, A. (2006) · Journal of Proteome Research · doi:10.1021/pr050361j · Cited by 1,109
Physical Activity, Diet, and Risk of Alzheimer Disease
Scarmeas, N. (2009) · JAMA · doi:10.1001/jama.2009.1144 · Cited by 916
Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813 · cited 1×
“On the other hand, Smith et al 105 observed a significant reduction in the brain atrophy rate in elderly people with mild cognitive alterations who received supplementation with 0.8 mg/day of folic acid, 0.5 mg/day of vitamin B12, and 20 mg/day of vitamin B6 for 2 years.”
InfluentialDocosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial
Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., Galvin, J. E., Emond, J., Jack, C. R., Weiner, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1510 · Cited by 764
Mediterranean Diet and Mild Cognitive Impairment
Scarmeas, N., Stern, Y., Mayeux, R., Manly, J. J., Schupf, N., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.536 · Cited by 757
Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia
Féart, C. (2009) · JAMA · doi:10.1001/jama.2009.1146 · Cited by 757
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Dietary patterns and risk of dementia: The Three-City cohort study
Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J. F., & Alpérovitch, A. (2007) · Neurology · doi:10.1212/01.wnl.0000278116.37320.52 · Cited by 700
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678 · cited 3×
“Morris et al 44 and Devore et al 45 associated a higher intake of vitamin E but not vitamin C with a lower long-term risk of dementia over a mean follow-up period of 2 years and 9.6 years, respectively.”
InfluentialHomocysteine and folate as risk factors for dementia and Alzheimer disease
Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., & Licastro, F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.636 · Cited by 500
A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging
Miller, J. A., Oldham, M. C., & Geschwind, D. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4098-07.2008 · Cited by 385
Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378 · cited 1×
“Cardoso et al 19 and Vural et al 20 observed lower activity of this enzyme family in AD patients compared to healthy individuals, while Parudariu et al 33 verified that dementia patients and patients with mild cognitive decline presented lower GPx1 activity.”
Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change
Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., Wilson, R. S., Aggarwal, N. T., & Scherr, P. A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.508 · Cited by 302 · cited 1×
“48,53 Transition metals: zinc, iron, and copper Zn is one of the most important minerals for human metabolism.”
Reactive oxygen species in human health and disease
Castro, L., & Freeman, B. A. (2001) · Nutrition · doi:10.1016/s0899-9007(00)00570-0 · Cited by 296 · cited 1×
“15”
25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men
Slinin, Y., Paudel, M. L., Taylor, B. C., Fink, H. A., Ishani, A., Canales, M. T., Yaffe, K., Barrett-Connor, E., Orwoll, E. S., Shikany, J. M., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c7197b · Cited by 193 · cited 2×
“On the other hand, Slinin et al 84 found only a tendency toward an independent association between low serum concentrations of vitamin D (less than 20 ng/mL) and a risk of cognitive decline in a population of over 1600 North American men aged 65 years or older after a mean follow-up period of 4.6…”
InfluentialPlasma homocysteine levels and risk of Alzheimer disease
Luchsinger, J. A., Tang, M. X., Shea, S., Miller, J., Green, R., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000129504.60409.88 · Cited by 171 · cited 1×
“102 Despite a number of relevant results, Morris et al 94 claim that the evidence related to associations of B-complex vitamins (mainly folate) with parameters of cognitive decline are weak, due chiefly to study limitations.”
Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136 · cited 1×
“Elias et al 100 verified a significant inverse association between homocysteine levels and multiple cognitive abilities, such as abstract reasoning; new verbal learning and memory; verbal and visual memory; concentration, scanning, tracking, and executive performance; visual organization; and…”
Antioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older Adults
Gray, S. L., Anderson, M. L., Crane, P. K., Breitner, J. C. S., McCormick, W., Bowen, J. D., Teri, L., & Larson, E. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01531.x · Cited by 127 · cited 2×
“48 According to Brewer, 49 the controversial results found in various studies could be justified by incorrect dosage and timing, unbalanced monotherapy, or incorrect targets.”
Homocysteine and Cognitive Function in a Population‐Based Study of Older Adults
Schafer, J. H., Glass, T. A., Bolla, K. I., Mintz, M., Jedlicka, A. E., & Schwartz, B. S. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53153.x · Cited by 124 · cited 1×
“101 On the other hand, there have been reports that high homocysteine levels are not associated with AD and cognitive decline.”
Education Attenuates the Association between Dietary Patterns and Cognition
Akbaraly, T. N., Singh-Manoux, A., Marmot, M. G., & Brunner, E. J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000199235 · Cited by 90
Lovell, M. A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0992 · Cited by 87 · cited 1×
“70 Processing by the nonamyloidogenic pathway, which is catalyzed by one alpha-secretase and results in the formation of soluble APP, a neurotrophic factor, 71 may be influenced by Zn because APP presents a binding site for this metal at the position where alpha-secretase catalyzes the processing…”
Cited by
Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review
Yegambaram, M., Manivannan, B., Beach, T., & Halden, R. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150204121719 · Cited by 273
Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
Folch, J., Petrov, D., Ettcheto, M., Abad, S., Sánchez-López, E., García, M. L., Olloquequi, J., Beas-Zarate, C., Auladell, C., & Camins, A. (2016) · Neural Plasticity · doi:10.1155/2016/8501693 · Cited by 270
Characterization of biometal profiles in neurological disorders
Pfaender, S., & Grabrucker, A. M. (2014) · Metallomics · doi:10.1039/c4mt00008k · Cited by 117
Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy
Nehls, M. (2016) · Journal of Molecular Psychiatry · doi:10.1186/s40303-016-0018-8 · Cited by 41
“Therefore, management of potential micronutrients deficiencies can only be one, albeit important, aspect of AD prevention and treatment strategies (for review see [313, 330]).”
Background
Metadata
- Authors
- Cardoso, B., Cominetti, & Cozzolino
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2013-05
- Volume
- 8
- Pages
- 531
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- OpenAlex
- W2046763345
- Cited by
- 62
- References
- 25
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.